INMUNE BIO INTERNATIONAL LIMITED

Company number 10105962 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£22,635,805

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2016-04-06
Employees
12 (2025 accounts · was 7 in 2024)
Registered office
C/O Keystone Law )Attn:Simon Holden), 48 Chancery Lane, London, WC2A 1JF
Postcode
WC2A 1JF
Capital
10 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-04-05
Next due by
2027-04-19
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 2 current · 1 resigned

David MOSS Director
Appointed 2016-04-06
Appointed 2016-04-06

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZC049084 (Tier 1), registered since 2025.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Previous registered addresses 2

AddressChanged on
C/O KERMAN & CO LLP (ATTN: SIMON W. HOLDEN), 200 STRAND, LONDON, WC2R 1DJ, ENGLAND2019-10-12
C/O LESTER ALDRIDGE LLP (ATTN: SIMON W. HOLDEN), 1 KING STREET, LONDON, EC2V 8AU, ENGLAND2017-01-13

Among its peers

Among the biggest employers

of 46 similar companies in WC, with 12 staff. Among the oldest 25% of its local peers.

108 companies are registered at this postcode →

Competitors London

This company ranks 113 among research and experimental development on biotechnology in London.

Full league table →

The class of 2016

36%

of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →